EP Patent

EP0755923A1 — Ameliorant or remedy for symptoms caused by ischemic diseases and compounds useful therefor

Assigned to Asubio Pharma Co Ltd · Expires 1997-01-29 · 29y expired

What this patent protects

A medicine having the following basic structure, for the alleviation or treatment of symptoms derived from ischemic diseases and seizures, epilepsy, and migraine, having a powerful action in suppressing cytotoxic Ca 2+ overload and free from side-effects: wherein Z = C…

USPTO Abstract

A medicine having the following basic structure, for the alleviation or treatment of symptoms derived from ischemic diseases and seizures, epilepsy, and migraine, having a powerful action in suppressing cytotoxic Ca 2+ overload and free from side-effects: wherein Z = C, CH, or N, X = O or CH 2 , E and Y = H, OH, a halogen, alkoxy, alkyl, or a halogen-substituted alkyl.

Drugs covered by this patent

Patent Metadata

Patent number
EP0755923A1
Jurisdiction
EP
Classification
Expires
1997-01-29
Drug substance claim
No
Drug product claim
No
Assignee
Asubio Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.